Joinn Laboratories(China)Co.,Ltd.
603127
Rankning i aktier
#3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Aktiekurs
$6.82
Marknadsvärde
$4.30B
Förändring (1 dag)
-6.30%
Förändring (1 år)
184.21%
Land
CN
Handel Joinn Laboratories(China)Co.,Ltd. (603127)
Kategori
Healthcare
Aktiekurshistorik för Joinn Laboratories(China)Co.,Ltd. (603127)
Högsta slutkurs: $3.68 den 2026-10-01
Lägsta slutkurs: $6.48 den 2021-02-01
Lägsta slutkurs: $6.48 den 2021-02-01
Aktiekurshistorik för Joinn Laboratories(China)Co.,Ltd. från 2021 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 11.18% |
| 2025 | 111.15% |
| 2024 | -23.74% |
| 2023 | -55.34% |
| 2022 | -30.77% |
| 2021 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $676.48 | 19.27% |
US
|
|
| $229.93 | 5.42% |
US
|
|
| $398.85 | 112.13% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.35 | 19.52% |
US
|
